Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.

Antoch, Gerald

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Mar 2004 - 357-65 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Validation Study

0161-5505


Adult
Aged
Antineoplastic Agents--therapeutic use
Benzamides
Female
Gastrointestinal Neoplasms--diagnosis
Humans
Imatinib Mesylate
Male
Middle Aged
Piperazines--therapeutic use
Prognosis
Pyrimidines--therapeutic use
Reproducibility of Results
Sensitivity and Specificity
Stromal Cells--diagnostic imaging
Subtraction Technique
Tomography, Emission-Computed--methods
Tomography, X-Ray Computed--methods
Treatment Outcome